Lyso-GL-3 is a potential biomarker associated with clinical manifestation of Fabry disease in some patients. Elevated plasma Lyso-GL-3 levels occur in some Fabry patients. Lyso-GL-3 may be used to monitor treatment.
Frozen (preferred) - 3 months
Freeze/thaw x 6
Clotted or severely hemolyzed plasma samples
LC/MS
ng/mL